vimarsana.com

“This year, there is no need for immediate cash infusion in Apollo HealthCo. It is being supported by Rs 130 crore of EBITDA coming from the backend pharmacy. So, there is cash for growth existing within the company and at the right valuation, we will look at a 10% dilution.”

Related Keywords

Lucknow ,Uttar Pradesh ,India ,Pune ,Maharashtra ,Kolkata ,West Bengal ,Kozhikode ,Kerala ,Apollo Healthco ,Suneeta Reddy ,Offering College ,Indian School Of Business ,Apollo Hospitals ,Leadership Excellence ,Operations Officer ,Product Officer ,Might Also Like ,Apollo Hospitals Share Price ,Gmv ,Ebitda ,Expert View ,Stock Market ,Et Now ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.